Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Boni

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Lancet (London, England)|September 4, 1993
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriA C Wotherspoon, C Doglioni, T C Diss, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2010
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up studyM Rugge, M de Boni, G Pennelli, et al.
Minerva Gastroenterologica E Dietologica|June 1, 1993
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer]F Di Mario, G A Grasso, G Battaglia, et al.
Clinical Therapeutics|November 1, 1994
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderlyA Pilotto, F Di Mario, G Battaglia, et al.
British Journal of Haematology|June 1, 1997
Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection processF Bertoni, G Cazzaniga, G Bosshard, et al.
The Italian Journal of Gastroenterology|May 1, 1991
Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?F Farinati, F Di Mario, M Plebani, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2012
Autoimmune gastritis: histology phenotype and OLGA stagingM Rugge, M Fassan, M Pizzi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Lancet (London, England)|September 4, 1993
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriA C Wotherspoon, C Doglioni, T C Diss, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2010
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up studyM Rugge, M de Boni, G Pennelli, et al.
Minerva Gastroenterologica E Dietologica|June 1, 1993
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer]F Di Mario, G A Grasso, G Battaglia, et al.
Clinical Therapeutics|November 1, 1994
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderlyA Pilotto, F Di Mario, G Battaglia, et al.
British Journal of Haematology|June 1, 1997
Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection processF Bertoni, G Cazzaniga, G Bosshard, et al.
The Italian Journal of Gastroenterology|May 1, 1991
Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?F Farinati, F Di Mario, M Plebani, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2012
Autoimmune gastritis: histology phenotype and OLGA stagingM Rugge, M Fassan, M Pizzi, et al.
Pageof 2